Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks receptors for estrogen (ER) and progesterone (PR), as well as overexpression of human epidermal growth factor receptor 2 (HER2) proteins [1,2]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.